FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...

Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

“These impairments often persist even during periods of symptom remission and can have a profound impact on daily functioning and quality of life,” says Caroline Fenkel, a doctor of social ...

As LB Pharmaceuticals enters a pivotal stage of growth, the additions of Gad and Richard to our leadership team reinforce our ability to execute on our ambitious clinical and regulatory goals,” said ...

In a notable Genomic Press research report, researchers at the Aristotle University of Thessaloniki have uncovered a significant presence of manic symptoms in patients with schizophrenia spectrum ...

Upward telemedicine trends in schizophrenia treatment were rapid after the COVID-19 pandemic, particularly in state-operated agencies.

A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...

A protocol designed to progressively increase physical therapy intensity for stroke survivors improved walking distance, ...

Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, a new study says.

A report into the care received by Nottingham triple killer Valdo Calocane shows he may have been “spared prison on the basis ...